Skip to main content

and
Your search also matched 9 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Chirurgische Eingriffe bei Patienten mit systemischer Mastzellaktivierungserkrankung

Include preview-only content
  1. Article

    Open Access

    Adrenal insufficiency is a contraindication for omalizumab therapy in mast cell activation disease: risk for serum sickness

    Omalizumab is an effective therapeutic humanized murine IgE antibody in many cases of primary systemic mast cell activation disease (MCAD). The present study should enable the clinician to recognize when treat...

    G. J. Molderings, F. L. Dumoulin, J. Homann in Naunyn-Schmiedeberg's Archives of Pharmaco… (2020)